These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 32248188)
1. Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option. Yaprak G; Isık N; Gemici C; Pekyurek M; Ceylaner Bıcakcı B; Demircioglu F; Tatarlı N Stereotact Funct Neurosurg; 2020; 98(3):167-175. PubMed ID: 32248188 [TBL] [Abstract][Full Text] [Related]
2. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery. Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L J Neurosurg; 2019 Aug; 131(2):489-499. PubMed ID: 30485180 [TBL] [Abstract][Full Text] [Related]
3. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era. Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102 [TBL] [Abstract][Full Text] [Related]
4. Hypofractionated stereotactic reirradiation for recurrent glioblastoma. Yazici G; Cengiz M; Ozyigit G; Eren G; Yildiz F; Akyol F; Gurkaynak M; Zorlu F J Neurooncol; 2014 Oct; 120(1):117-23. PubMed ID: 25012955 [TBL] [Abstract][Full Text] [Related]
5. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. Patel M; Siddiqui F; Jin JY; Mikkelsen T; Rosenblum M; Movsas B; Ryu S J Neurooncol; 2009 Apr; 92(2):185-91. PubMed ID: 19066727 [TBL] [Abstract][Full Text] [Related]
6. Re-irradiation with radiosurgery for recurrent glioblastoma multiforme. Torok JA; Wegner RE; Mintz AH; Heron DE; Burton SA Technol Cancer Res Treat; 2011 Jun; 10(3):253-8. PubMed ID: 21517131 [TBL] [Abstract][Full Text] [Related]
7. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252 [TBL] [Abstract][Full Text] [Related]
8. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327 [TBL] [Abstract][Full Text] [Related]
9. Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience. Ciammella P; Podgornii A; Galeandro M; D'Abbiero N; Pisanello A; Botti A; Cagni E; Iori M; Iotti C Radiat Oncol; 2013 Sep; 8():222. PubMed ID: 24066926 [TBL] [Abstract][Full Text] [Related]
11. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241 [TBL] [Abstract][Full Text] [Related]
12. Outcome of salvage treatment for recurrent glioblastoma. Kim HR; Kim KH; Kong DS; Seol HJ; Nam DH; Lim DH; Lee JI J Clin Neurosci; 2015 Mar; 22(3):468-73. PubMed ID: 25595963 [TBL] [Abstract][Full Text] [Related]
14. Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes. Lewin R; Amit U; Laufer M; Berger R; Dotan Z; Domachevsky L; Davidson T; Portnoy O; Tsvang L; Ben-Ayun M; Weiss I; Symon Z Radiat Oncol; 2021 Jun; 16(1):114. PubMed ID: 34162398 [TBL] [Abstract][Full Text] [Related]
15. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years' experience of a single center. Yilmaz MT; Kahvecioglu A; Yazici G; Mohammadipour S; Kertmen N; Cifci GC; Zorlu F J Neurooncol; 2024 Apr; 167(2):295-303. PubMed ID: 38383875 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity of CyberKnife re-irradiation and "dose dense" temozolomide for recurrent gliomas. Conti A; Pontoriero A; Arpa D; Siragusa C; Tomasello C; Romanelli P; Cardali S; Granata F; De Renzis C; Tomasello F Acta Neurochir (Wien); 2012 Feb; 154(2):203-9. PubMed ID: 21984132 [TBL] [Abstract][Full Text] [Related]
17. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy. Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234 [TBL] [Abstract][Full Text] [Related]
18. Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy. Dincoglan F; Beyzadeoglu M; Sager O; Demiral S; Gamsiz H; Uysal B; Ebruli C; Akin M; Oysul K; Sirin S; Dirican B Tumori; 2015; 101(2):179-84. PubMed ID: 25791534 [TBL] [Abstract][Full Text] [Related]
19. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution. Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095 [TBL] [Abstract][Full Text] [Related]
20. Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse. Tong E; Horsley P; Wheeler H; Wong M; Venkatesha V; Chan J; Kastelan M; Back M J Neurooncol; 2024 May; 168(1):69-76. PubMed ID: 38551747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]